Effect of sotalol on heart rate variability in patients with atrial fibrillation (clinical observation)
https://doi.org/10.33667/2078-5631-2020-2-32-36
Abstract
Spectral analysis of heart rate variability gives an idea of the role of the autonomic nervous system in the regulation of chronotropic heart function. This method can be used to evaluate the effectiveness of drug therapy. Drug therapy should be carried out taking into account the individual clinical form of atrial fibrillation. Information about the vegetative status of the patient will undoubtedly increase the effectiveness of treatment. In this study, spectral parameters were studied in patients with atrial fibrillation. The effect of sotalol on the spectral parameters of heart rate variability was studied.
About the Authors
E. P. Popova
First Moscow State Medical University n. a. I. M. Sechenov
Russian Federation
Russian Federation
Moscow
O. T. Bogova
Medical Academy for Postgraduate Continuous Education
Russian Federation
Russian Federation
Moscow
S. N. Puzin
First Moscow State Medical University n. a. I. M. Sechenov; Medical Academy for Postgraduate Continuous Education; Federal Research Clinical Center for Resuscitation and Rehabilitation
Russian Federation
Russian Federation
Moscow; Lytkino, Moscow Region
D. A. Sychyov
Medical Academy for Postgraduate Continuous Education
Russian Federation
Russian Federation
Moscow
V. P. Fisenko
First Moscow State Medical University n. a. I. M. Sechenov
Russian Federation
Russian Federation
Moscow
References
1. Баевский Р. М., Иванов И. И., Чирейкин Л. В. и др. Анализ вариабельности сердечного ритма при использовании различных электрокардиографических систем (методические рекомендации). // Вестник Аритмологии. – 2001. – № 24. – С. 65–87.
2. Искендеров Б. Г., Рахматуллов Ф. К. Структурные и электрофизиологические показатели функции сердца при пароксизмальной мерцательной аритмии. // Тер. архив. – 2001. – № 12. – С. 52–56.
3. Флейшман А. Н., Филимонов С. Н., Климина Н. В. Новый способ подбора препаратов для лечения артериальной гипертонии на основе спектрального анализа вариабельности ритма сердца. // Тер. Архив. – 2001. – № 12. – С. 33–39.
4. Akselrod S., Eds M. Malik, A. J. Camm. Components of heart rate variability. Basis studies. In: Heart Rate Variability. // Armonk. N.-Y. Futura Pablishity. Comp. Inc. – 1995. – Р. 147–163.
5. Gal P., Elvan A., Rossi P. et al. Effect of parasympathetic nerve stimulation on atrial and atrioventricular nodal electrophysiological characteristics. // Int. J. Cardiol. – 2016. – Vol. 205. P. 83–85.
6. Hanley C. M., Robinson V. M., Peter R. Kowey P. R. Status of Antiarrhythmic Drug Development for Atrial Fibrillation. New Drugs and New Molecular Mechanisms. // Circ. Arrhythm Electrophysiol. – 2016. – Vol. 9, N 3. – P. 1–9.
7. Hohendanner F., Heinzel F. R., Blaschke F. et al. Pathophysiological and therapeutic implications in patients with atrial fibrillation and heart failure. // Heart Fail Rev. – 2018. – Vol. 23, N 1. – P. 27–36.
8. Kirchhof P., Breithardt G., Bax J. et al. A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network. // European Heart Rhythm Association consensus conference. Europace. – 2016. – Vol. 18, N 1. P. 37–50.
9. Lok N. S., Lau C. P. Abnormal vasovagal reaction, autonomic function, and heart rate variability in patients with paroxysmal atrial fibrillation. // Pacing Clin. Electrophysiol. – 1998. – Vol. 21, N 2. P. 386–395.
10. Patel P. A., Ali N., Hogarth A., Tayebjee M. H. Management strategies for atrial fibrillation. // J. R. Soc. Med. – 2017. – Vol. 110, N 1. – P. 13–22.
11. Stavrakis S., Humphrey M. B., Scherlag B. J. et al. Low-level transcutaneous electrical vagus nerve stimulation suppresses atrial fibrillation. // J. Am. Coll. Cardiol. – 2015. – Vol. 65. – P. 867–75.
12. Task Force of the European Society of Cardiology and the North American Society of Paciety of Pacing and Electrophysiology. Heart rate variability. Standards of measurements, physiological interpretation and clinical use. // Circulation. – 1996. – Vol., N 93. – P. 1043–1065.
13. Wang Z., Page P., Nattel S. Mechanism of flecainide’s antiarrhythmic action in experimental atrial fibrillation. // Circ. Res. – 1992. – Vol. 71, N 2. – P. 271–287.
14. Орлова Н. В., Федулаев Ю. Н. Школа здоровья для пациентов с фибрилляцией предсердий.// CardioСоматика. – 2019. – Т. 10. – № 3. – С. 50–59.
Review
For citations:
Popova E.P., Bogova O.T., Puzin S.N., Sychyov D.A., Fisenko V.P. Effect of sotalol on heart rate variability in patients with atrial fibrillation (clinical observation). Medical alphabet. 2020;(2):32-36. (In Russ.) https://doi.org/10.33667/2078-5631-2020-2-32-36
Views:
528
Email this article 